TrialAnnals of the American Thoracic Society2021

Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.

Mark T Dransfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.